Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming
结内趋化因子辅助抗肿瘤免疫启动的机制动力学研究
基本信息
- 批准号:8233500
- 负责人:
- 金额:$ 32.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-03-01 至 2016-02-29
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAffectAnimalsAntigen PresentationAntigen-Presenting CellsAntigensAreaBiological AssayCCL3 geneCCL4 geneCCR1 geneCD4 Positive T LymphocytesCD8B1 geneCXCR3 geneCell CommunicationCellsCommunicationCross PresentationDendritic CellsDevelopmentDiseaseEngineeringEquilibriumEvaluationFutureGene Expression ProfileGenerationsGoalsHost resistanceImmuneImmune ToleranceImmune responseImmune systemImmunityImmunizationImmunotherapeutic agentImmunotherapyIn SituIndividualInfectionInflammatoryInvestigationKineticsLaboratoriesLaser Scanning MicroscopyLymphocyteLymphoidMaintenanceMalignant NeoplasmsMediatingMediator of activation proteinMemoryMethodsModelingMolecularMolecular TargetOccupationsOrganPathogenesisPhotonsPlayProtocols documentationRelative (related person)RoleSensitivity and SpecificitySeriesSiteSmall Inducible Cytokine A3SpecificitySurfaceSystemT cell responseT memory cellT-Cell ActivationT-Cell DevelopmentT-LymphocyteTechnologyTestingTimeTissue-Specific Gene ExpressionTissuesTumor AntigensTumor ImmunityVaccinationarmcell typechemokinechemokine receptorcytotoxicdesignimmune activationimprovedin vivoinsightlymph nodesmigrationneoplastic cellnovelnovel therapeuticsparacrinepathogenpublic health relevancereceptor expressionresearch studysuccesstherapy designtumorvaccination strategy
项目摘要
DESCRIPTION (provided by applicant): The job of our immune system is to recognize foreign invaders and eliminate the threat while ignoring host tissues. Tissue microenvironment plays a critical role in orchestrating the generation of immune responses, including adaptive memory T cell immunity. Understanding how tissue microenvironment affects the balance between immune activation and unresponsiveness in vivo is crucial in defining pathogenesis of diseases such as cancer. It is also helpful in taking advantage of the exquisite sensitivity and specificity of the immune system in developing the next generation of therapeutic and vaccination strategies. Recently application of intravital 2-photon laser scanning microscopy in examining immune tissue organization and immune cellular orchestration in vivo has yielded new insights into the critical contribution of inflammatory chemokines in orchestrating efficient cell-cell cooperation among various arms of the adaptive immune response. Using animal tumor models genetically engineered to secrete inflammatory chemokines such as CCL3 and CCL4, we propose to undertake a series of studies to investigate how efficient cell-cell interaction among tumor-associated antigen presenting cells, CD4+T cells, CD8+ T cells, and tumor cells may be achieved to accomplish efficacious generation of long-term, protective anti-tumor T cell responses. We also outline an ambitious goal to directly observe, for the first time, dynamic cellular interplay in metastatic lymph nodes including direct antigen presentation by tumors and cross-presentation of tumor-associated antigens by host antigen-presenting cells during the induction of an effective immune response. This will be accomplished by utilizing the state-of-the-art 2-photon laser scanning microscopy available in our own laboratory. Success in this endeavor not only will yield new insights into how to employ inflammatory chemokines as an adjuvant in the generation of anti-tumor CD8+ memory T cells, but also will provide direct in vivo evidence for the roles which the host APC and tumors play in priming CD8+ T cells against tumor-associated antigen. A detailed understanding of the intricate cellular recruitment and communication in the tumor microenvironment will allow the development of targeted therapies designed to enhance anti-tumor immune activation. It will also provide insights into factors that will enhance targeting and recruitment of cytotoxic anti-tumor lymphocytes to tumor sites in currently existing immunotherapy protocols.
PUBLIC HEALTH RELEVANCE: Ultimately, any effective cellular immunotherapy against cancer must accomplish 2 goals: 1) Finding effective adjuvant to enhance efficient generation and maintenance of long-term anti-tumor immunity; 2) Proper and rapid recruitment of relevant immune cells to sites of tumor-antigen priming, activation and effector delivery. This study seeks to investigate the cellular mechanism of enhanced anti-tumor effect by inflammatory chemokines such as CCL3 and CCL4, and the associated chemokine receptor(s). We propose to employ the state-of-the-art 2-photon laser scanning microscopy technology in order to accomplish this goal. Successful execution of this project will not only provide new insights into novel tumor immunotherapy approaches, but will also demonstrate a new in situ experimental platform to test future anti-tumor immune strategies with high cellular specificity.
描述(由申请人提供):我们的免疫系统的工作是识别外来入侵者并消除威胁,同时忽略宿主组织。组织微环境在协调免疫反应(包括适应性记忆 T 细胞免疫)的产生中发挥着关键作用。了解组织微环境如何影响体内免疫激活和无反应之间的平衡对于确定癌症等疾病的发病机制至关重要。它还有助于利用免疫系统的精致敏感性和特异性来开发下一代治疗和疫苗接种策略。最近,应用活体 2 光子激光扫描显微镜检查体内免疫组织组织和免疫细胞编排,对炎症趋化因子在协调适应性免疫反应各分支之间有效细胞间合作的关键贡献产生了新的见解。利用基因工程改造的动物肿瘤模型来分泌炎症趋化因子(如 CCL3 和 CCL4),我们建议进行一系列研究,以研究肿瘤相关抗原呈递细胞、CD4+T 细胞、CD8+T 细胞和肿瘤细胞可以实现有效产生长期的、保护性的抗肿瘤T细胞应答。我们还概述了一个雄心勃勃的目标,即首次直接观察转移淋巴结中的动态细胞相互作用,包括肿瘤的直接抗原呈递和宿主抗原呈递细胞在诱导有效免疫过程中交叉呈递肿瘤相关抗原。回复。这将通过利用我们自己实验室中最先进的 2 光子激光扫描显微镜来实现。这项工作的成功不仅将为如何利用炎症趋化因子作为抗肿瘤 CD8+ 记忆 T 细胞的佐剂提供新的见解,而且还将为宿主 APC 和肿瘤在抗肿瘤过程中发挥的作用提供直接的体内证据。启动 CD8+ T 细胞对抗肿瘤相关抗原。对肿瘤微环境中复杂的细胞募集和通讯的详细了解将有助于开发旨在增强抗肿瘤免疫激活的靶向疗法。它还将提供对在当前现有免疫治疗方案中增强细胞毒性抗肿瘤淋巴细胞靶向和招募至肿瘤位点的因素的见解。
公共健康相关性:最终,任何有效的癌症细胞免疫疗法都必须实现两个目标:1)找到有效的佐剂以增强长期抗肿瘤免疫力的有效产生和维持; 2) 正确、快速地将相关免疫细胞募集到肿瘤抗原引发、激活和效应物传递的位点。本研究旨在探讨 CCL3 和 CCL4 等炎症趋化因子以及相关趋化因子受体增强抗肿瘤作用的细胞机制。我们建议采用最先进的 2 光子激光扫描显微镜技术来实现这一目标。该项目的成功执行不仅将为新型肿瘤免疫治疗方法提供新的见解,还将展示一个新的原位实验平台来测试未来具有高细胞特异性的抗肿瘤免疫策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alex Yee-Chen Huang其他文献
Alex Yee-Chen Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alex Yee-Chen Huang', 18)}}的其他基金
Targeting VCAM1-a4b1 Signaling to Ameliorate Pulmonary Osteosarcoma Metastasis
靶向 VCAM1-a4b1 信号传导以改善肺骨肉瘤转移
- 批准号:
9375804 - 财政年份:2017
- 资助金额:
$ 32.58万 - 项目类别:
Cdk5 signaling in ICN1-induced T Cell Leukemogenesis
ICN1 诱导的 T 细胞白血病发生中的 Cdk5 信号传导
- 批准号:
8802979 - 财政年份:2015
- 资助金额:
$ 32.58万 - 项目类别:
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming
结内趋化因子辅助抗肿瘤免疫启动的机制动力学研究
- 批准号:
8444284 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming
结内趋化因子辅助抗肿瘤免疫启动的机制动力学研究
- 批准号:
8461866 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming
结内趋化因子辅助抗肿瘤免疫启动的机制动力学研究
- 批准号:
8020491 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming
结内趋化因子辅助抗肿瘤免疫启动的机制动力学研究
- 批准号:
8795280 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
Real-time Measurement of Self-antigen Recognition by Lymphocytes In Vivo
体内淋巴细胞自身抗原识别的实时测量
- 批准号:
8191110 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming
结内趋化因子辅助抗肿瘤免疫启动的机制动力学研究
- 批准号:
8623746 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
Real-time Measurement of Self-antigen Recognition by Lymphocytes In Vivo
体内淋巴细胞自身抗原识别的实时测量
- 批准号:
8263743 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
Mechanistic Dynamic Study of Intranodal Chemokine-aided Antitumor Immune Priming
结内趋化因子辅助抗肿瘤免疫启动的机制动力学研究
- 批准号:
8616727 - 财政年份:2011
- 资助金额:
$ 32.58万 - 项目类别:
相似国自然基金
城市化对土壤动物宿主-寄生虫关系的影响机制研究
- 批准号:32301430
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
三江源国家公园黄河源园区食草野生动物与放牧家畜冲突的强度、影响及未来情景
- 批准号:42371283
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
十年禁渔对赤水河底栖动物群落多样性及其维持机制的影响
- 批准号:32301370
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
两栖动物(蛙类)对新型卤代有机污染物的生物富集及其对污染物环境迁移影响的研究
- 批准号:42307349
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
土壤动物对草地生态系统地下食物网碳氮传输过程及土壤有机质形成的影响
- 批准号:32301359
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Project 3: Credentialing CDK 4/6 inhibitors used with radiation as an effective treatment strategy in locally advanced ER+ and TNBC
项目 3:认证 CDK 4/6 抑制剂与放射结合使用作为局部晚期 ER 和 TNBC 的有效治疗策略
- 批准号:
10554474 - 财政年份:2023
- 资助金额:
$ 32.58万 - 项目类别:
Preclinical assessment of a novel systemic drug candidate for osteoarthritic pain
治疗骨关节炎疼痛的新型全身候选药物的临床前评估
- 批准号:
10642544 - 财政年份:2023
- 资助金额:
$ 32.58万 - 项目类别:
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 32.58万 - 项目类别:
Development of broadly-protective vaccines for influenza B viruses
开发针对乙型流感病毒的广泛保护性疫苗
- 批准号:
10821572 - 财政年份:2023
- 资助金额:
$ 32.58万 - 项目类别:
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
- 批准号:
10636329 - 财政年份:2023
- 资助金额:
$ 32.58万 - 项目类别: